This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Anaeropharma Science, Inc.. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Suwa, JP (2013)
- Tokyo, JP (2017)
Company Filing History:
Years Active: 2013-2017
Title: Hiromi Yonekura: Innovator in Therapeutic Agents
Introduction
Hiromi Yonekura is a notable inventor based in Suwa, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of ischemic and anaerobic diseases. With a total of 3 patents to his name, Yonekura is recognized for his innovative approaches to medical treatments.
Latest Patents
Yonekura's latest patents include a therapeutic agent for ischemic diseases. This invention aims to provide a gene transfer carrier that specifically accumulates at disease sites, ensuring high protein expression rates while disappearing as the disease is treated. The solution involves a gene transfer carrier formed from an anaerobic bacterium that can grow at ischemic disease sites and express proteins useful for diagnosis or treatment.
Another significant patent is a therapeutic agent for anaerobic diseases, such as solid tumors. This invention combines a pharmaceutical composition containing a transformed anaerobic microorganism with a colonization and growth enhancer. This enhancer promotes the specific colonization and proliferation of the anaerobic microorganism at disease sites in anaerobic environments.
Career Highlights
Yonekura is currently associated with Anaeropharma Science, Inc., where he continues to develop innovative therapeutic solutions. His work focuses on enhancing treatment efficacy for diseases that pose significant challenges in the medical field.
Collaborations
Yonekura collaborates with talented individuals such as Yuko Shimatani-Shibata and Takayuki Sasaki. These collaborations contribute to the advancement of research and development in therapeutic agents.
Conclusion
Hiromi Yonekura's contributions to the field of therapeutic agents highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to addressing complex health challenges through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile